The "Vascular Access Device Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering.
The vascular access device market is rapidly advancing as hospitals, care providers, and manufacturers intensify their focus on safety, patient outcomes, and clinical efficiency. Innovation in device technology and evolving care models are transforming operations, procurement strategies, and regulatory compliance for healthcare decision-makers.
Market Snapshot: Vascular Access Device Market Growth and Outlook
The global vascular access device market grew from USD 5.11 billion in 2024 to USD 5.48 billion in 2025. Forecasts indicate continued expansion at a CAGR of 7.90%, reaching USD 9.39 billion by 2032. This sustained growth reflects the sector's response to increasing chronic disease prevalence, the demands of aging populations, and the need for reliable intravenous access in a wide array of clinical settings.
Scope & Segmentation of the Vascular Access Device Market
This market report thoroughly examines key segments and regional dynamics critical for strategic decisions by senior stakeholders. Segmentation addresses diverse use cases, application settings, and patient populations alongside a technology-focused view.
- Type: Central venous catheters, peripheral vascular access devices, long peripheral intravenous catheters, short peripheral intravenous catheters
- Age Group: Adult, geriatric, pediatric
- End User: Ambulatory surgical centers, home healthcare settings, hospitals & clinics
- Application: Blood transfusion, diagnostics & testing, drug administration, antibiotic infusion, chemotherapy
- Region: Americas (North America: United States, Canada, Mexico; Latin America: Brazil, Argentina, Chile, Colombia, Peru), Europe, Middle East & Africa (Europe: United Kingdom, Germany, France, Russia, Italy, Spain, Netherlands, Sweden, Poland, Switzerland; Middle East: United Arab Emirates, Saudi Arabia, Qatar, Turkey, Israel; Africa: South Africa, Nigeria, Egypt, Kenya), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Malaysia, Singapore, Taiwan)
Key Takeaways for Senior Decision-Makers
- Technological progress, including advanced polymers and sensor integration, is driving adoption of devices that streamline insertion workflows while improving patient safety.
- Infection prevention and outcome measurement have led to increased investment in antimicrobial coatings, real-time monitoring, and ergonomic product designs adapted for varied patient demographics.
- New international guidelines on biocompatibility and post-market surveillance are extending product development timelines and shaping design lifecycles for manufacturers.
- The shift toward home-based care and telehealth services is boosting demand for user-friendly devices, spurring focus on client training and safe, effective outpatient care models.
- Collaboration among stakeholders, from manufacturers to payers, is accelerating the development of patient-centric, data-driven solutions that balance efficacy, safety, and cost containment.
Tariff Impact on Supply Chains and Strategies
The introduction of 2025 United States tariffs on vascular access devices has significantly altered supply chains and cost structures. Manufacturers are responding by relocating assembly operations closer to end markets and renegotiating supplier agreements to mitigate duty expenses. This shift also influences procurement choices, leading to portfolio diversification, operational investments, and new volume-based negotiation strategies among hospitals and group purchasing organizations.
Methodology & Data Sources
This research draws on a blend of primary interviews with clinicians, procurement leaders, and industry experts, as well as secondary reviews of regulatory filings, peer-reviewed publications, and proprietary data sets. Advanced scenario modeling and rigorous cross-validation underpin all insights.
Why This Report Matters
- Inform strategic planning with a clear breakdown of market segments, technology trends, and region-specific opportunities.
- Evaluate competitor actions and innovation cycles to guide investment decisions and build resilient sourcing frameworks.
- Gain actionable insight to optimize procurement, operational efficiency, and adaptation to regulatory shifts within the vascular access device market.
Conclusion
Continued transformation in the vascular access device sector hinges on technology adoption, regulatory alignment, and stakeholder collaboration. Robust strategies that prioritize safety, operational flexibility, and market responsiveness are now essential for sustainable leadership in this evolving market.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 197 |
| Forecast Period | 2025 - 2032 |
| Estimated Market Value (USD) in 2025 | $5.48 Billion |
| Forecasted Market Value (USD) by 2032 | $9.39 Billion |
| Compound Annual Growth Rate | 7.9% |
| Regions Covered | Global |
Key Topics Covered
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Rising adoption of antimicrobial-impregnated central venous catheters to reduce bloodstream infections
5.2. Integration of IoT-enabled pressure sensors in vascular access ports for continuous flow monitoring and data analytics
5.3. Growing demand for ultrasound-guided peripheral intravenous catheters in outpatient oncology and infusion clinics
5.4. Emergence of closed system transfer devices for needleless drug administration to improve safety and compliance
5.5. Widening use of midline catheters in home healthcare for prolonged antibiotic and nutrition infusion therapies
5.6. Development of bioresorbable polymeric vascular grafts to address small vessel disease in diabetic patient populations
5.7. Surge in robotic-assisted insertion systems for central venous access to enhance precision and reduce procedural complications
5.8. Increasing regulatory approvals for needle-free connectors with antimicrobial barrier technology to curb contamination risks
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Vascular Access Device Market, by Type
8.1. Central Venous Catheters
8.2. Peripheral Vascular Access Devices
8.2.1. Long Peripheral Intravenous Catheter
8.2.2. Short Peripheral Intravenous Catheter
9. Vascular Access Device Market, by Age Group
9.1. Adult
9.2. Geriatric
9.3. Pediatric
10. Vascular Access Device Market, by End User
10.1. Ambulatory Surgical Centers
10.2. Home Healthcare Settings
10.3. Hospitals & Clinics
11. Vascular Access Device Market, by Application
11.1. Blood Transfusion
11.2. Diagnostics & Testing
11.3. Drug Administration
11.3.1. Antibiotic Infusion
11.3.2. Chemotherapy
12. Vascular Access Device Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Vascular Access Device Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Vascular Access Device Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
The companies profiled in this Vascular Access Device market report include:
- 3M Company
- Access Vascular, Inc.
- AMECATH
- AngioDynamics, Inc.
- Argon Medical Devices, Inc.
- Asahi Kasei Medical Co., Ltd.
- B. Braun Melsungen AG
- Baxter International Inc.
- Becton, Dickinson and Company
- Cook Medical, Inc.
- Edwards Lifesciences Corporation
- Fresenius Medical Care AG & Co. KGaA
- Fujifilm Sonosite, Inc.
- ICU Medical, Inc.
- Kimal PLC
- Medical Components, Inc.
- Medtronic PLC
- Nipro Medical Corporation
- Prodimed
- Semler Technologies Inc.
- Siemens Healthcare AG
- Smiths Medical, Inc.
- Teleflex Incorporated
- Terumo Corporation
- Versago Vascular Access
- Vygon SA
- W. L. Gore & Associates, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/kvql05
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251121976637/en/
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
